Protein Mapping Study Reveals Valuable Clues for COVID-19 Drug Development
NIH Director's Blog: Drug Development
OCTOBER 27, 2020
That’s the strategy employed by remdesivir , the only antiviral drug currently authorized by the U.S. Food and Drug Administration to treat COVID-19. Another promising strategy is drugs that target the proteins within human cells that the virus needs to infect, multiply, and spread.
Let's personalize your content